Showing 3,101 - 3,120 results of 18,343 for search 'significantly ((((((larger decrease) OR (teer decrease))) OR (a decrease))) OR (mean decrease))', query time: 0.53s Refine Results
  1. 3101

    Principal coordinates analysis (PCoA). by Wararak Choovanichvong (22110371)

    Published 2025
    “…Analysis of bacterial abundance revealed a shift in trends as the disease combined from control to NSESKD and SESKD group, respectively, across 7 genera: <i><i>Actinobacillus</i></i>, <i>TM7x</i>, <i><i>Capnocytophaga</i></i>, <i><i>Neisseria</i></i>, and <i><i>Leptotrichia</i></i> increased in abundance, while <i><i>Actinomyces</i></i> and <i><i>Atopobium</i></i> decreased. …”
  2. 3102
  3. 3103
  4. 3104

    Initial participants by wave*. by Yeo Ju Sohn (18536198)

    Published 2024
    “…<div><p>Background</p><p>Diabetes mellitus (DM) is a significant public health concern, particularly in the elderly population. …”
  5. 3105

    General characteristics of research participants. by Yeo Ju Sohn (18536198)

    Published 2024
    “…<div><p>Background</p><p>Diabetes mellitus (DM) is a significant public health concern, particularly in the elderly population. …”
  6. 3106

    Singling Out the Electrochemiluminescence Profile in Microelectrode Arrays by Chiara Mariani (20716841)

    Published 2025
    “…In contrast, a significant narrowing of the ECL profile was observed on Au, indicative of a transition from a catalytic to an oxidative–reductive pathway. …”
  7. 3107

    Singling Out the Electrochemiluminescence Profile in Microelectrode Arrays by Chiara Mariani (20716841)

    Published 2025
    “…In contrast, a significant narrowing of the ECL profile was observed on Au, indicative of a transition from a catalytic to an oxidative–reductive pathway. …”
  8. 3108
  9. 3109
  10. 3110
  11. 3111
  12. 3112
  13. 3113

    Table2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  14. 3114

    Table1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  15. 3115
  16. 3116
  17. 3117
  18. 3118
  19. 3119
  20. 3120